Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01262937 · ClinicalTrials.gov registry record
A Study to Examine the Human Gastrointestinal Tract Using the Confocal Endomicroscope
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 106
- Enrollment target
NCT01262937: Clinical Trial study, sponsored by Yale University.
NCT01262937 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01262937 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 106 participants
- Enrollment target
Study Summary
The goal of the project is to determine whether confocal endomicroscopy can be used to identify and discriminate among dysplastic, neoplastic, and nonneoplastic tissue, as compared with histologic specimens as a reference. The project will evaluate those at risk for or with known Barrett's esophagus, and those with known or suspected biliary strictures. It is our hypothesis that we will be able to identify between neoplastic and nonneoplastic tissue.
Interventions
- DEVICE Confocal Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2009-07 |
| Est. Completion | 2016-07 |
Why NCT01262937 stopped before completion
NCT01262937 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Confocal Imaging is the first listed.
NCT01262937 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01262937 about?
NCT01262937 is a clinical study titled "A Study to Examine the Human Gastrointestinal Tract Using the Confocal Endomicroscope". The goal of the project is to determine whether confocal endomicroscopy can be used to identify and discriminate among dysplastic, neoplastic, and nonneoplastic tissue, as compared with histologic specimens as a reference. The project will evaluate those at risk for or with known Barrett's esophagus...
What is the current status of trial NCT01262937?
This trial is currently terminated. The enrollment target is 106 participants. The study started on 2009-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01262937?
The interventions under investigation include: Confocal Imaging (DEVICE).
Who is sponsoring clinical trial NCT01262937?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia